Skip to main content
Premium Trial:

Request an Annual Quote

BGI, G10K Set Goals for Next Stage in Animal Sequencing Collaboration

NEW YORK (GenomeWeb) – BGI and the Genome 10K Consortium today announced the next phase of their collaboration to sequence the genomes of vertebrate species.

In Phase II of their collaboration, BGI and G10K will fund and execute the sequencing of the genomes of 10,000 vertebrate species, with a goal of completing the task by 2020. The partners said in a statement that they will "adhere to the highest standards" of genome assembly, annotation, alignment, and analysis.

The Global Invertebrate Genome Alliance will also organize the sequencing of the genomes of several hundred marine invertebrates as part of the project, BGI and G10K said.

In 2010, the partners collaborated to sequence 100 vertebrate genomes, with the goal of doing it in two years. That phase of the project has been completed, and the number of vertebrate taxa sequenced to date globally is almost 300 species, they said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more